1. Home
  2. SCYX vs WAVE Comparison

SCYX vs WAVE Comparison

Compare SCYX & WAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • WAVE
  • Stock Information
  • Founded
  • SCYX 1999
  • WAVE 2011
  • Country
  • SCYX United States
  • WAVE Israel
  • Employees
  • SCYX N/A
  • WAVE N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • WAVE Electric Utilities: Central
  • Sector
  • SCYX Health Care
  • WAVE Utilities
  • Exchange
  • SCYX Nasdaq
  • WAVE Nasdaq
  • Market Cap
  • SCYX 28.5M
  • WAVE 53.4M
  • IPO Year
  • SCYX 2014
  • WAVE 2021
  • Fundamental
  • Price
  • SCYX $0.70
  • WAVE $8.58
  • Analyst Decision
  • SCYX
  • WAVE Strong Buy
  • Analyst Count
  • SCYX 0
  • WAVE 1
  • Target Price
  • SCYX N/A
  • WAVE $15.00
  • AVG Volume (30 Days)
  • SCYX 182.9K
  • WAVE 25.0K
  • Earning Date
  • SCYX 08-07-2025
  • WAVE 08-28-2025
  • Dividend Yield
  • SCYX N/A
  • WAVE N/A
  • EPS Growth
  • SCYX N/A
  • WAVE N/A
  • EPS
  • SCYX N/A
  • WAVE N/A
  • Revenue
  • SCYX $2,630,000.00
  • WAVE $168,000.00
  • Revenue This Year
  • SCYX $410.22
  • WAVE $325.00
  • Revenue Next Year
  • SCYX $248.83
  • WAVE $85.71
  • P/E Ratio
  • SCYX N/A
  • WAVE N/A
  • Revenue Growth
  • SCYX N/A
  • WAVE N/A
  • 52 Week Low
  • SCYX $0.66
  • WAVE $2.50
  • 52 Week High
  • SCYX $2.21
  • WAVE $17.63
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 43.16
  • WAVE 59.41
  • Support Level
  • SCYX $0.67
  • WAVE $7.53
  • Resistance Level
  • SCYX $0.74
  • WAVE $9.83
  • Average True Range (ATR)
  • SCYX 0.04
  • WAVE 0.76
  • MACD
  • SCYX 0.00
  • WAVE 0.11
  • Stochastic Oscillator
  • SCYX 18.79
  • WAVE 57.48

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.

Share on Social Networks: